HCA Healthcare Inc [HCA] stock prices are up 0.22% to $316.91 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The HCA shares have gain 0.57% over the last week, with a monthly amount drifted -5.91%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
HCA Healthcare Inc [NYSE: HCA] stock has seen the most recent analyst activity on May 30, 2024, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $396. Previously, Barclays started tracking the stock with Overweight rating on March 06, 2024, and set its price target to $356. On January 04, 2024, downgrade downgraded it’s rating to Mkt Perform and revised its price target to $301 on the stock. Goldman downgraded its rating to a Neutral but stick to its price target of $271 on December 11, 2023. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $304 as its price target on April 21, 2023. In a note dated July 06, 2022, BMO Capital Markets downgraded an Underperform rating on this stock and revised its target price from $233 to $160.
The stock price of HCA Healthcare Inc [HCA] has been fluctuating between $215.96 and $344.20 over the past year. Currently, Wall Street analysts expect the stock to reach $281.95 within the next 12 months. HCA Healthcare Inc [NYSE: HCA] shares were valued at $316.91 at the most recent close of the market. An investor can expect a potential drop of -11.03% based on the average HCA price forecast.
Analyzing the HCA fundamentals
The HCA Healthcare Inc [NYSE:HCA] reported sales of 66.72B for trailing twelve months, representing a surge of 11.21%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is -2.68 and Total Capital is 0.22. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -24.89.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 314.32 points at the first support level, and at 311.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 319.83, and for the 2nd resistance point, it is at 322.76.
Ratios To Look Out For
It’s worth pointing out that HCA Healthcare Inc [NYSE:HCA]’s Current Ratio is 1.16. On the other hand, the Quick Ratio is 1.02, and the Cash Ratio is 0.1. Considering the valuation of this stock, the price to sales ratio is 1.24 and price to earnings (TTM) ratio is 15.79.
Transactions by insiders
Recent insider trading involved Whalen Kathleen M, SVP & Chief Ethics Officer, that happened on May 16 ’24 when 3204.0 shares were sold. SVP-Payer Contracting & Align., Torres Kathryn A. completed a deal on May 15 ’24 to sell 1863.0 shares. Meanwhile, EVP and Chief Clinical Officer Cuffe Michael S. sold 6311.0 shares on May 09 ’24.
